RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
…
Rockwood Research

Corporate filings · Event Monitor · Free for all

← Back

Faeth Therapeutics, Inc.

FTH

Pharmaceutical Preparations · SIC 2834 · CIK 0001829802

SHARE:XLINKEDINEMAIL
Revenue FY2025
—
Net Income
$(21.0M)
EPS (Basic)
$-16.72
Net Margin
—
ROE
-113.4%
Total Equity
$19.0M
Shares Out
26M

Faeth Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Revenue & Net Income (10Y)

Margin Trends

Investor Ownership · 4 funds in our universe

FundPosition Value% of AUMQoQ ChgWeight
Suvretta Capital Management
Suvretta Capital Management
$50.5M
1.1%
+5,747.1%
Vivo Capital
Vivo Capital
$18.1M
0.3%
—
Baker Bros. Advisors
Baker Bros. Advisors
$32.2M
0.1%
NEW
RA Capital Management
RA Capital Management
$18.1M
0.1%
NEW

Insider Transactions

Reading stored insider transactions…